Skip to main content
Journal cover image

Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.

Publication ,  Journal Article
Palmer, K; Green, TD; Roberts, JL; Sajaroff, E; Cooney, M; Parrott, R; Chen, D-F; Reinsmoen, NL; Buckley, RH
Published in: J Allergy Clin Immunol
August 2007

The persistence of transplacentally transferred maternal T cells is common in infants with severe combined immunodeficiency (SCID), occurring in more than half of patients with SCID undergoing transplantation at our institution. These T cells respond poorly to mitogens in vitro but can cause cutaneous graft-versus-host disease; however, other effects of these cells are unknown. We describe 2 infants with SCID who had unusual problems associated with transplacentally transferred maternal T cells. Patient 1 was a 5-month-old girl with Janus kinase 3-deficient SCID who had 4% circulating CD3(+) T cells but no lymphocyte proliferative response to mitogens. Although the number of T cells increased after 2 nonchemoablated, T cell-depleted, haploidentical, paternal bone marrow transplantations, T-cell function failed to develop, and she became pancytopenic. Restriction fragment length polymorphism studies of flow cytometry-sorted blood T cells revealed all to be of maternal origin. A subsequent nonchemoablated, T cell-depleted maternal transplantation resulted in normal T-cell function and marrow recovery. Patient 2 was a 9-month-old girl with IL-7Ralpha-deficient SCID who presented with autoimmune pancytopenia. She had 8% blood T cells (all CD45RO(+)) but no response to mitogens. High-resolution HLA sequence-specific priming typing detected both maternal haplotypes, indicating the presence of maternal cells. Her pancytopenia resolved after treatment with rituximab and was thought to be due to host B-cell activation by transplacentally acquired maternal T cells. Persistent transplacentally acquired maternal T cells in infants with SCID can mediate immunologic functions despite failing to respond to mitogens in vitro. We present evidence that these cells can cause allograft rejection and immune cytopenias.

Duke Scholars

Published In

J Allergy Clin Immunol

DOI

ISSN

0091-6749

Publication Date

August 2007

Volume

120

Issue

2

Start / End Page

423 / 428

Location

United States

Related Subject Headings

  • T-Lymphocytes
  • Severe Combined Immunodeficiency
  • Rituximab
  • Reoperation
  • Receptors, Interleukin-7
  • Pancytopenia
  • Mitogens
  • Lymphocytes
  • Leukocyte Common Antigens
  • Janus Kinase 3
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Palmer, K., Green, T. D., Roberts, J. L., Sajaroff, E., Cooney, M., Parrott, R., … Buckley, R. H. (2007). Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency. J Allergy Clin Immunol, 120(2), 423–428. https://doi.org/10.1016/j.jaci.2007.02.047
Palmer, Kricia, Todd D. Green, Joseph L. Roberts, Elisa Sajaroff, Myriah Cooney, Roberta Parrott, Dong-Feng Chen, Nancy L. Reinsmoen, and Rebecca H. Buckley. “Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.J Allergy Clin Immunol 120, no. 2 (August 2007): 423–28. https://doi.org/10.1016/j.jaci.2007.02.047.
Palmer K, Green TD, Roberts JL, Sajaroff E, Cooney M, Parrott R, et al. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency. J Allergy Clin Immunol. 2007 Aug;120(2):423–8.
Palmer, Kricia, et al. “Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.J Allergy Clin Immunol, vol. 120, no. 2, Aug. 2007, pp. 423–28. Pubmed, doi:10.1016/j.jaci.2007.02.047.
Palmer K, Green TD, Roberts JL, Sajaroff E, Cooney M, Parrott R, Chen D-F, Reinsmoen NL, Buckley RH. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency. J Allergy Clin Immunol. 2007 Aug;120(2):423–428.
Journal cover image

Published In

J Allergy Clin Immunol

DOI

ISSN

0091-6749

Publication Date

August 2007

Volume

120

Issue

2

Start / End Page

423 / 428

Location

United States

Related Subject Headings

  • T-Lymphocytes
  • Severe Combined Immunodeficiency
  • Rituximab
  • Reoperation
  • Receptors, Interleukin-7
  • Pancytopenia
  • Mitogens
  • Lymphocytes
  • Leukocyte Common Antigens
  • Janus Kinase 3